Sommaire

Numéro précédent | Numéro suivant

• • ·Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non–ST-segment elevation acute myocardial infarction (the ARMADA study)

    Page :925-930

    Gilles Montalescot, Claire Bal-dit-Sollier, Daniela Chibedi, Jean-Philippe Collet, Thierry Soulat, Miles Dalby, R.émi Choussat, Ariel Cohen, Michel Slama, Phillipe Gabriel Steg, Jean-Luc Dubois-Randé, Jean-Philippe Metzger, François Tarragano, Jean L Guermonprez, Ludovic Drouet, ARMADA Investigators

    Résumé Résumé Plan Plan  
• • ·Impact of high-sensitivity c-reactive protein on predicting long-term mortality of acute myocardial infarction

    Page :931-935

    Kunihiro Kinjo, Hiroshi Sato, Yozo Ohnishi, Eiji Hishida, Daisaku Nakatani, Hiroya Mizuno, Katsuji Imai, Shinsuke Nanto, Masashi Naka, Yasushi Matsumura, Hiroshi Takeda, Masatsugu Hori, Osaka Acute Coronary Insufficiency Study (OACIS) Group

    Résumé Résumé Plan Plan  
• • ·Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes

    Page :936-940

    Sunil V Rao, E.Magnus Ohman, Christopher B Granger, Paul W Armstrong, W.Brian Gibler, Robert H Christenson, Vic Hasselblad, Amanda Stebbins, Steven McNulty, L.Kristin Newby

    Résumé Résumé Plan Plan  
• • ·Clinical, exercise electrocardiographic, and pharmacologic stress echocardiographic findings for risk stratification of hypertensive patients with chest pain

    Page :941-945

    Lauro Cortigiani, Claudio Coletta, Riccardo Bigi, Elisabetta Amici, Alessandro Desideri, Leonardo Odoguardi

    Résumé Résumé Plan Plan  
• • ·A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention

    Page :946-950

    Babak A Vakili, Robert C Kaplan, James N Slater, Warren Sherman, Kumar L Ravi, Stephen J Green, Timothy A Sanborn, David L Brown

    Résumé Résumé Plan Plan
• • ·Immediate and long-term clinical outcome after spinal cord stimulation for refractory stable angina pectoris

    Page :951-955

    Francesco Di Pede, Gaetano Antonio Lanza, Guerrino Zuin, Ottavio Alfieri, Massimo Rapati, Massimo Romanò, Antonio Circo, Paola Cardano, Fulvio Bellocci, Massimo Santini, Attilio Maseri, Investigators of the Prospective Italian Registry of SCS for Angina Pectoris

    Résumé Résumé Plan Plan  
• • ·Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome

    Page :956-960

    Gloria Lena Vega, Patrick T.S Ma, Nilo B Cater, Neil Filipchuk, Shinichi Meguro, Ana Barbara Garcia-Garcia, Scott M Grundy

    Résumé Résumé Plan Plan
• • ·Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia

    Page :961-964

    Charles P Lucas, Mark N Boldrin, Gerald M Reaven

    Résumé Résumé Plan Plan  
• • ·Comparison of subjective perception of myocardial ischemia produced by coronary balloon occlusion in patients with versus those without type 2 diabetes mellitus

    Page :965-968

    Patrick H McNulty, Steven M Ettinger, Joseph Gascho, Ian C Gilchrist, Amir Piracha, Mark Kozak, Charles E Chambers

     
• • ·Association between gender and In-Hospital mortality after percutaneous coronary intervention according to age

    Page :968-971

    Jerome L Abramson, Emir Veledar, William S Weintraub, Viola Vaccarino

     
• • ·Predictors of progression of native coronary narrowing to total occlusion after coronary artery bypass grafting

    Page :971-974

    Kyle K. Pond, Gary V. Martin, Nathan Every, Kenneth G. Lehmann, Richard Anderson, James H. Caldwell, Samir R. Kapadia

     
• • ·Gadolinium-enhanced coronary angiography in patients with impaired renal function

    Page :974-975

    Antoine Sarkis, Georges Badaoui, Rabih Azar, Ghassan Sleilaty, Rania Bassil, Victor A. Jebara

     
• • ·Association of an activated clotting time ≤250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy)

    Page :976-978

    Duane S. Pinto, David P. Lorenz, Sabina A. Murphy, Susan J. Marble, Peter M. DiBattiste, Laura A. Demopoulos, Christopher P. Cannon, C.Michael Gibson, TIMI Study Group

     
• • ·Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries

    Page :979-981

    Dale T Ashby, Roxana Mehran, Eve A Aymong, Alexandra J Lansky, Ioannis Iakovou, Giora Weisz, Gishel New, Issam Moussa, George Dangas, Jeffery W Moses, Gregg W Stone, Martin B Leon

    
• • ·Chlamydia pneumoniae antibodies and endothelial function as assessed by flow-mediated dilation in patients with chest pain with and without ischemic heart disease

    Page :982-985

    Beata B. Malmqvist, Birgitte R. Diness, Kim Krogsgaard, Lars H. Thomassen, Gorm B. Jensen, IAMA Group* *

    
• • ·Outcomes in patients with coronary heart disease who do not undergo lipid testing

    Page :986-988

    P.Michael Ho, Charles Maynard, Helene Starks, Haili Sun, Kevin Sloan, Anne Sales

    
• • ·Effect of postmenopausal hormone therapy on coronary heart disease events after percutaneous transluminal coronary angioplasty

    Page :989-991

    Masroor A Khan, Mark A Hlatky, Ming W Liu, Feng Lin, William J Rogers, Michael G Shlipak, HERS Investigators

    
• • ·Volumetric assessment of ulcerated ruptured coronary plaques with three-dimensional intravascular ultrasound in vivo

    Page :992-996

    Mario Gössl, Clemens von Birgelen, Gary S. Mintz, Dirk Böse, Holger Eggebrecht, Dietrich Baumgart, Michael Haude, Raimund Erbel

     
• • ·Angiographic assessment of myocardial perfusion in patients with isolated coronary artery ectasia

    Page :996-999

    Sadi Gulec, Yusuf Atmaca, Mustafa Kilickap, Omer Akyürek, Omer Aras, Dervis Oral

     
• • ·Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin

    Page :999-1002

    Heather M Abourjaily, Alawi A Alsheikh-Ali, Richard H Karas*

     
• • ·Factors associated with ventricular inducibility in the MADIT-II study population

    Page :1002-1004

    Henry W. Sesselberg, Arthur J. Moss, Jonathan Steinberg, Elizabeth Carroll, Wojciech Zareba, James Daubert, David T. Huang

    
• • ·Effect of interatrial block on coronary sinus contraction

    Page :1004-1006

    Husam H Farah, David H Spodick

     
• • ·Prevalence and triggers of syncope in medical students

    Page :1006-1008

    Karin S. Ganzeboom, Nancy Colman, Johannes B. Reitsma, Win K. Shen, Wouter Wieling

     
• • ·Effect of exercise training on blood pressure in postmenopausal Caucasian and African-American women

    Page :1009-1011

    Helena Santa-Clara, Linda Szymanski, B.o Fernhall

    
• • ·Influence of co-morbidity on cost of care for heart failure

    Page :1011-1015

    William S Weintraub, Hugh Kawabata, Michele Tran, Gilbert J L’Italien, Roland S Chen

    
• • ·Diagnostic challenges defining heart failure when using echocardiograms

    Page :1015-1017

    Usha Subramanian, Morris Weinberger, Stephan D. Fihn, William M. Tierney

    
• • ·Percutaneous transvenous mitral valvulotomy normalizes elevated circulating levels of tumor necrosis factor-⍺ and interleukin-6 in mitral stenosis with heart failure

    Page :1018-1020

    Chi-Jen Chang, Lung-A.n Hsu, Cheng-Wen Chiang, Y.u-Shien Ko, Lai-Chu See, Yung-Chi Shen, Y.u-Lin Ko, Chi-Tai Kou, Ying-Shiung Lee, Jong-Hwei S Pang

     
• • ·Screening for hypertrophic cardiomyopathy in a young male military population

    Page :1021-1023

    Stefano Nistri, Gaetano Thiene, Cristina Basso, Domenico Corrado, Antonio Vitolo, Barry J Maron

    
• • ·Serum levels of matrix metalloproteinases and tumor necrosis factor-⍺ in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels

    Page :1024-1027

    Tomoaki Ohtsuka, Mareomi Hamada, Hideyuki Saeki, Akiyoshi Ogimoto, Yuji Hara, Yuji Shigematsu, Jitsuo Higaki

     
• • ·Reliability of intraoperative contrast transesophageal echocardography for detecting interatrial communications in patients with other congenital cardiovascular malformations

    Page :1027-1031

    Lydia Cassorla, Wanda C Miller-Hance, Kathryn Rouine-Rapp, V.Mohan Reddy, Frank L Hanley, Norman H Silverman

    
• • ·Effect of high-dose spironolactone on protein-losing enteropathy in patients with Fontan palliation of complex congenital heart disease

    Page :1031-1032

    Richard E Ringel, Stacie B Peddy

    
• • ·Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension

    Page :1033-1037

    Alan L. Hinderliter, Park W. Willis, Walker A. Long, William R. Clarke, David Ralph, Edgar J. Caldwell, William Williams, Neil A. Ettinger, Nicholas S. Hill, Warren R. Summer, Bennett de Boisblanc, Gary Koch, Shu Li, Linda M. Clayton, Maria M. Jöbsis, James W. Crow, PPH Study Group* *

     
• • ·Comparison of accuracy of left ventricular echocardiographic measurements by fundamental imaging versus second harmonic imaging

    Page :1037-1039

    Nicolas Mansencal, Pierre Bordachar, Gilles Chatellier, Alban Redheuil, Benoît Diebold, Eric Abergel

     
• • ·Does living alone affect the outcome of acute myocardial infarction?

    Page :1040

    Kenneth E. Freedland, Robert M. Carney